Please wait
S-8 S-8 EX-FILING FEES 0001672619 Enliven Therapeutics, Inc. N/A Fees to be Paid 0001672619 2025-12-15 2025-12-15 0001672619 1 2025-12-15 2025-12-15 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

Enliven Therapeutics, Inc.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Common Stock, par value $0.001 per share, reserved for issuance pursuant to the Registrant's 2025 Inducement Equity Incentive Plan Other 875,000 $ 17.72 $ 15,505,000.00 0.0001381 $ 2,141.25

Total Offering Amounts:

$ 15,505,000.00

$ 2,141.25

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 2,141.25

Offering Note

1

Represents shares of common stock, par value $0.001 per share (the "Common Stock") of Enliven Therapeutics, Inc. (the "Registrant") available for issuance pursuant to awards granted pursuant to the Registrant's 2025 Inducement Equity Incentive Plan (the "Inducement Plan"). Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the "Securities Act"), this registration statement on Form S-8 (the "Registration Statement") shall also cover any additional shares of the Registrant's Common Stock that become issuable with respect to the securities identified in the above table under the Inducement Plan by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the registrant's receipt of consideration which results in an increase in the number of outstanding shares of Common Stock. Estimated in accordance with Rule 457(c) and Rule 457(h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $17.72 per share, which is the average of the high and low prices of Common Stock, as reported on The Nasdaq Global Select Market, on December 12, 2025, which date is within five business days prior to the filing of this Registration Statement.
Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Fee Offset Sources N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A